Clinical study of ocular manifestations in patients with newly diagnosed and relapsed hematolymphoid malignancies at a tertiary care hospital

Objectives: To estimate the proportion of ocular manifestations in new and relapsed cases of various hematolymphoid malignancies and to determine an association between these ocular manifestations and the hematological parameters of the patients. Materials and Methods: The study was conducted in the...

Полное описание

Библиографические подробности
Главные авторы: Deepthi Rameshbabu Honniganur, Thanuja Gopal Pradeep, Santhosh Kumar Devadas
Формат: Статья
Язык:English
Опубликовано: Wolters Kluwer Medknow Publications 2024-05-01
Серии:Journal of Clinical Ophthalmology and Research
Предметы:
Online-ссылка:https://journals.lww.com/jcor/fulltext/2024/12020/clinical_study_of_ocular_manifestations_in.12.aspx
_version_ 1827137057548402688
author Deepthi Rameshbabu Honniganur
Thanuja Gopal Pradeep
Santhosh Kumar Devadas
author_facet Deepthi Rameshbabu Honniganur
Thanuja Gopal Pradeep
Santhosh Kumar Devadas
author_sort Deepthi Rameshbabu Honniganur
collection DOAJ
description Objectives: To estimate the proportion of ocular manifestations in new and relapsed cases of various hematolymphoid malignancies and to determine an association between these ocular manifestations and the hematological parameters of the patients. Materials and Methods: The study was conducted in the department of ophthalmology in association with medical oncology. All patients with newly diagnosed or presenting with a relapse of hematolymphoid malignancies underwent a complete ocular evaluation. Results: A total of 63 patients were included in this study. The mean age of the patients was 34.71 ± 19.80 years. Acute myeloid leukemia and B-ALL accounted for 73% of the cases. At the time of examination, 47.61% of patients (n = 30) were newly diagnosed and 52.38% (n = 33) had relapsed. Acute leukemias had more probability of having ocular manifestations than chronic leukemias (P = 0.01). Subconjunctival hemorrhage was found to be the most common anterior segment finding (n = 10, 15.87%; P = 0.05). The most common posterior segment finding seen in both the right and left eyes was dot blot hemorrhages (n = 20). Those patients who had hemoglobin counts <6.5 mg/dl had the most ophthalmic manifestations (n = 20); of which Roth spots were seen the most (n = 6; P = 0.04). And those who had platelet counts <50,000 cells/cumm presented with Roth spots (n = 6, P = 0.05) followed by subretinal hemorrhages (n = 5, P = 0.05) and preretinal hemorrhages (n = 5, P = 0.05). Conclusion: Screening to detect ocular manifestations is of importance in hematolymphoid malignancy, especially in newly detected and relapsed cases. A complete ocular examination is recommended in these patients, as most patients are asymptomatic and ocular manifestation could be an early sign of worsening of the disease. Among the various blood parameters, low hemoglobin and platelet counts are definite indicators of the presence of intraretinal bleeding manifestations.
first_indexed 2025-03-20T18:01:24Z
format Article
id doaj.art-c4331b7ad044422b84eefb58c3b75ce4
institution Directory Open Access Journal
issn 2320-3897
2320-3900
language English
last_indexed 2025-03-20T18:01:24Z
publishDate 2024-05-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Clinical Ophthalmology and Research
spelling doaj.art-c4331b7ad044422b84eefb58c3b75ce42024-08-27T07:30:44ZengWolters Kluwer Medknow PublicationsJournal of Clinical Ophthalmology and Research2320-38972320-39002024-05-0112212412910.4103/jcor.jcor_33_24Clinical study of ocular manifestations in patients with newly diagnosed and relapsed hematolymphoid malignancies at a tertiary care hospitalDeepthi Rameshbabu HonniganurThanuja Gopal PradeepSanthosh Kumar DevadasObjectives: To estimate the proportion of ocular manifestations in new and relapsed cases of various hematolymphoid malignancies and to determine an association between these ocular manifestations and the hematological parameters of the patients. Materials and Methods: The study was conducted in the department of ophthalmology in association with medical oncology. All patients with newly diagnosed or presenting with a relapse of hematolymphoid malignancies underwent a complete ocular evaluation. Results: A total of 63 patients were included in this study. The mean age of the patients was 34.71 ± 19.80 years. Acute myeloid leukemia and B-ALL accounted for 73% of the cases. At the time of examination, 47.61% of patients (n = 30) were newly diagnosed and 52.38% (n = 33) had relapsed. Acute leukemias had more probability of having ocular manifestations than chronic leukemias (P = 0.01). Subconjunctival hemorrhage was found to be the most common anterior segment finding (n = 10, 15.87%; P = 0.05). The most common posterior segment finding seen in both the right and left eyes was dot blot hemorrhages (n = 20). Those patients who had hemoglobin counts <6.5 mg/dl had the most ophthalmic manifestations (n = 20); of which Roth spots were seen the most (n = 6; P = 0.04). And those who had platelet counts <50,000 cells/cumm presented with Roth spots (n = 6, P = 0.05) followed by subretinal hemorrhages (n = 5, P = 0.05) and preretinal hemorrhages (n = 5, P = 0.05). Conclusion: Screening to detect ocular manifestations is of importance in hematolymphoid malignancy, especially in newly detected and relapsed cases. A complete ocular examination is recommended in these patients, as most patients are asymptomatic and ocular manifestation could be an early sign of worsening of the disease. Among the various blood parameters, low hemoglobin and platelet counts are definite indicators of the presence of intraretinal bleeding manifestations.https://journals.lww.com/jcor/fulltext/2024/12020/clinical_study_of_ocular_manifestations_in.12.aspxanterior segment manifestationshematolymphoid malignancyleukemialymphomaocular manifestationsposterior segment manifestationsroth spots
spellingShingle Deepthi Rameshbabu Honniganur
Thanuja Gopal Pradeep
Santhosh Kumar Devadas
Clinical study of ocular manifestations in patients with newly diagnosed and relapsed hematolymphoid malignancies at a tertiary care hospital
Journal of Clinical Ophthalmology and Research
anterior segment manifestations
hematolymphoid malignancy
leukemia
lymphoma
ocular manifestations
posterior segment manifestations
roth spots
title Clinical study of ocular manifestations in patients with newly diagnosed and relapsed hematolymphoid malignancies at a tertiary care hospital
title_full Clinical study of ocular manifestations in patients with newly diagnosed and relapsed hematolymphoid malignancies at a tertiary care hospital
title_fullStr Clinical study of ocular manifestations in patients with newly diagnosed and relapsed hematolymphoid malignancies at a tertiary care hospital
title_full_unstemmed Clinical study of ocular manifestations in patients with newly diagnosed and relapsed hematolymphoid malignancies at a tertiary care hospital
title_short Clinical study of ocular manifestations in patients with newly diagnosed and relapsed hematolymphoid malignancies at a tertiary care hospital
title_sort clinical study of ocular manifestations in patients with newly diagnosed and relapsed hematolymphoid malignancies at a tertiary care hospital
topic anterior segment manifestations
hematolymphoid malignancy
leukemia
lymphoma
ocular manifestations
posterior segment manifestations
roth spots
url https://journals.lww.com/jcor/fulltext/2024/12020/clinical_study_of_ocular_manifestations_in.12.aspx
work_keys_str_mv AT deepthirameshbabuhonniganur clinicalstudyofocularmanifestationsinpatientswithnewlydiagnosedandrelapsedhematolymphoidmalignanciesatatertiarycarehospital
AT thanujagopalpradeep clinicalstudyofocularmanifestationsinpatientswithnewlydiagnosedandrelapsedhematolymphoidmalignanciesatatertiarycarehospital
AT santhoshkumardevadas clinicalstudyofocularmanifestationsinpatientswithnewlydiagnosedandrelapsedhematolymphoidmalignanciesatatertiarycarehospital